Cargando…
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
As COVID-19 vaccinations became available and were proven effective in preventing serious infection, uptake amongst individuals varied, including in medically vulnerable populations. This cross-sectional multi-site study examined vaccine uptake, hesitancy, and explanatory factors amongst people with...
Autores principales: | Day, Daphne, Grech, Lisa, Nguyen, Mike, Bain, Nathan, Kwok, Alastair, Harris, Sam, Chau, Hieu, Chan, Bryan, Blennerhassett, Richard, Nott, Louise, Hamad, Nada, Tognela, Annette, Hoffman, David, McCartney, Amelia, Webber, Kate, Wong, Jennifer, Underhill, Craig, Sillars, Brett, Winkel, Antony, Savage, Mark, Loe, Bao Sheng, Freeman, Daniel, Segelov, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230066/ https://www.ncbi.nlm.nih.gov/pubmed/35746458 http://dx.doi.org/10.3390/vaccines10060851 |
Ejemplares similares
-
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
por: Bain, Nathan, et al.
Publicado: (2022) -
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
por: Choi, Tammie, et al.
Publicado: (2023) -
1614P Influence of cancer on COVID-19 vaccine beliefs, attitudes and uptake
por: Nguyen, M., et al.
Publicado: (2022) -
COVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis
por: Grech, Lisa, et al.
Publicado: (2023) -
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)